SE9603283D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9603283D0
SE9603283D0 SE9603283A SE9603283A SE9603283D0 SE 9603283 D0 SE9603283 D0 SE 9603283D0 SE 9603283 A SE9603283 A SE 9603283A SE 9603283 A SE9603283 A SE 9603283A SE 9603283 D0 SE9603283 D0 SE 9603283D0
Authority
SE
Sweden
Prior art keywords
pct
group
alkoxy
sec
amino
Prior art date
Application number
SE9603283A
Other languages
English (en)
Inventor
Haakan Bergstrand
Thomas Hoegberg
Kostas Karabelas
Anders Tunek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9603283A priority Critical patent/SE9603283D0/sv
Publication of SE9603283D0 publication Critical patent/SE9603283D0/sv
Priority to ZA9707807A priority patent/ZA977807B/xx
Priority to PCT/SE1997/001504 priority patent/WO1998011102A1/en
Priority to US08/981,003 priority patent/US6153641A/en
Priority to NZ334201A priority patent/NZ334201A/en
Priority to AU41431/97A priority patent/AU718844B2/en
Priority to CA002264236A priority patent/CA2264236A1/en
Priority to EP97939316A priority patent/EP0925296A1/en
Priority to ARP970104132A priority patent/AR008177A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9603283A 1996-09-10 1996-09-10 New compounds SE9603283D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9603283A SE9603283D0 (sv) 1996-09-10 1996-09-10 New compounds
ZA9707807A ZA977807B (en) 1996-09-10 1997-08-29 New pharmaceutically active compounds.
PCT/SE1997/001504 WO1998011102A1 (en) 1996-09-10 1997-09-08 New pharmaceutically active compounds
US08/981,003 US6153641A (en) 1996-09-10 1997-09-08 Pharmaceutically active compounds
NZ334201A NZ334201A (en) 1996-09-10 1997-09-08 Bisindolylmaleimide derivative linked via an indolyl nitrogen to an alkyl terminated with an aryl or heteroaryl
AU41431/97A AU718844B2 (en) 1996-09-10 1997-09-08 New pharmaceutically active compounds
CA002264236A CA2264236A1 (en) 1996-09-10 1997-09-08 New pharmaceutically active compounds
EP97939316A EP0925296A1 (en) 1996-09-10 1997-09-08 New pharmaceutically active compounds
ARP970104132A AR008177A1 (es) 1996-09-10 1997-09-10 Nuevas bisindolilmaleimidas, sales de las mismas, procesos para su preparacion intermediarios, su uso para la fabricacion de medicamentos, metodode tratamiento y composicion farmaceutica.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603283A SE9603283D0 (sv) 1996-09-10 1996-09-10 New compounds

Publications (1)

Publication Number Publication Date
SE9603283D0 true SE9603283D0 (sv) 1996-09-10

Family

ID=20403828

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603283A SE9603283D0 (sv) 1996-09-10 1996-09-10 New compounds

Country Status (9)

Country Link
US (1) US6153641A (sv)
EP (1) EP0925296A1 (sv)
AR (1) AR008177A1 (sv)
AU (1) AU718844B2 (sv)
CA (1) CA2264236A1 (sv)
NZ (1) NZ334201A (sv)
SE (1) SE9603283D0 (sv)
WO (1) WO1998011102A1 (sv)
ZA (1) ZA977807B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017200A1 (es) 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos
US6103712A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for asthma
SE9800835D0 (sv) 1998-03-13 1998-03-13 Astra Ab New Compounds
US6492406B1 (en) 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
ATE326464T1 (de) 2000-12-08 2006-06-15 Ortho Mcneil Pharm Inc Indazolyl-substituierte pyrrolidin-verbindungen als kinase inhibitoren
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
KR20040091113A (ko) * 2002-03-08 2004-10-27 일라이 릴리 앤드 캄파니 피롤-2,5-디온 유도체 및 ｇｓｋ-3 억제제로서 그의 용도
JP2005531607A (ja) 2002-06-05 2005-10-20 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キナーゼ阻害剤として置換ピロリン
BR0311821A (pt) * 2002-06-05 2005-04-05 Janssen Pharmaceutica Nv Derivados de bisindolil-maleimid como inibidores de cinase
ATE406365T1 (de) 2003-06-13 2008-09-15 Janssen Pharmaceutica Nv Substituierte indazolyl(indolyl)maleimid-derivate als kinase inhibitoren
EP1734952A1 (en) * 2004-04-08 2006-12-27 Novartis AG Protein kinase c inhibitors for the treatment of autoimmune diseases and of transplant rejection
CN101133055B (zh) * 2005-02-09 2011-05-25 艾科优公司 用于治疗癌症的meleimide衍生物、药物组合物以及方法
EP2392574B1 (en) * 2007-06-22 2013-12-18 ArQule, Inc. Indolyl pyrrolidines for the treatment of cancer
BRPI0813355A2 (pt) * 2007-06-22 2014-12-30 Arqule Inc Compostos de quinazolinona e métodos de uso dos mesmos
CN101801961B (zh) * 2007-06-22 2014-09-24 艾科尔公司 吡咯烷酮、吡咯烷-2,5-二酮、吡咯烷和硫代琥珀酰亚胺衍生物、组合物以及治疗癌症的方法
US8871807B2 (en) 2008-03-28 2014-10-28 Ecolab Usa Inc. Detergents capable of cleaning, bleaching, sanitizing and/or disinfecting textiles including sulfoperoxycarboxylic acids
US20170209488A1 (en) 2014-07-17 2017-07-27 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CN106565517B (zh) * 2016-10-18 2018-08-17 湖南大学 一种由芳基甲烷衍生物和腈制备酰胺的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US28973A (en) * 1860-07-03 Potato-parer
US3821387A (en) * 1965-10-23 1974-06-28 Robins Co Inc A H The treatment of parkinsonism with 3-(omega-substituted alkyl)-indoles
US3821389A (en) * 1969-10-31 1974-06-28 Sherwin Williams Co Microbiocidal use of 1,2-benzisothiazolin-3-ones
FR2182915A1 (en) * 1972-03-30 1973-12-14 Nelson Res & Dev Substd indoles, benzimidazoles - as anti-immune agents , antitumour agents, serotonin inhibitors, hypnotics
US4031221A (en) * 1974-06-17 1977-06-21 American Hoechst Corporation Method of treating pain and hypertension
GB1500176A (en) * 1975-06-03 1978-02-08 Wyeth John & Brother Ltd Reduction process for the preparation of 1-unsubstituted 3-(2-hydroxyethyl)-indole derivatives
DE3132882A1 (de) * 1981-08-20 1983-03-03 Cassella Ag, 6000 Frankfurt Neue piperazinone, ihre herstellung und verwendung
US4727044A (en) * 1984-05-18 1988-02-23 Semiconductor Energy Laboratory Co., Ltd. Method of making a thin film transistor with laser recrystallized source and drain
CZ280738B6 (cs) * 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
GB9413975D0 (en) * 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
US5192770A (en) * 1990-12-07 1993-03-09 Syntex (U.S.A.) Inc. Serotonergic alpha-oxoacetamides
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides
EP0630241A1 (en) * 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
US5621101A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
DK0817627T3 (da) * 1993-12-23 2005-06-06 Lilly Co Eli Inhibitorer af proteinkinase C
EP0675125A1 (en) * 1994-03-18 1995-10-04 Kyowa Hakko Kogyo Co., Ltd. A therapeutic agent for thrombocytopenia and indolocarbazole derivatives
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
TW472045B (en) * 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
US5854285A (en) * 1997-04-03 1998-12-29 Natpro, Inc. Protein kinase inhibitor

Also Published As

Publication number Publication date
US6153641A (en) 2000-11-28
AR008177A1 (es) 1999-12-09
ZA977807B (en) 1998-03-10
AU718844B2 (en) 2000-04-20
EP0925296A1 (en) 1999-06-30
NZ334201A (en) 2001-02-23
WO1998011102A1 (en) 1998-03-19
AU4143197A (en) 1998-04-02
CA2264236A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
SE9603283D0 (sv) New compounds
DE69232907D1 (de) Neue heterocyclische/cyclische amine
ATE275545T1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
DK0613458T3 (da) Acykliske ethylendiaminderivater som substans P receptorantagonister
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
DK0677046T3 (da) Piperazinderivater som 5-HT-antagonister.
SE9703375D0 (sv) A new combination
CO4340623A1 (es) Derivados de indolina, metodo de preparacion y uso
ATE154021T1 (de) N-cyclohexyl benzamide derivate, ihre herstellungen und therapeutischen anwendungen
SE9703376D0 (sv) A new combination
MY113266A (en) New indol derivatives derivatives with high affinity 5-ht1a receptor.
SE8505887L (sv) Indoler
HUP0101469A2 (hu) 5-[(2-Imidazolidinilidén)-amino]-benzimidazol-származékok, előállításuk és alkalmazásuk javított metabolikus stabilitású alfa-adrenoceptor agonistákként
NO972938D0 (no) Farmasöytiske piperazinforbindelser
TW333532B (en) Benzopyrans
TR199900096T2 (xx) Bradykinin B2 antagonistleri olarak elveri�li N-benzensulfonil-L-prolin t�revleri.
DK0775143T3 (da) 3-substituerede 3H-2,3-benzodiazepinderivater, deres fremstilling og anvendelse som lægdemidler
SE9603285D0 (sv) New compounds
AR248127A1 (es) Procedimiento para la preparacion de nuevas 2-aminotetralinas sustituidas en la posicion 8.
HUP0303137A2 (hu) Kettős hatású antioxidáns és antiaritmiás szerek
HUP0000315A2 (hu) Heterociklusos szubsztituált pirrolidin-amid származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
ATE154010T1 (de) 2-phenyl- und 2-thienyl-(2)-piperidinderivate mit neuroprotektiven eigenschaften
ATE154601T1 (de) 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten
SE9603284D0 (sv) New compounds